Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,610,527 | 1,541,573 | 1,557,666 | 1,542,448 | 1,371,868 |
| Cost of Goods | 728,466 | 656,838 | 587,355 | 597,808 | 520,834 |
| Gross Profit | 882,061 | 884,735 | 970,311 | 944,640 | 851,034 |
| Operating Expenses | 854,116 | 774,047 | 731,746 | 748,218 | 700,498 |
| Operating Income | 28,411 | 111,526 | 238,920 | 197,230 | 151,370 |
| Interest Expense | 70,632 | 51,377 | 49,594 | 50,395 | 71,581 |
| Other Income | 23,984 | 20,920 | 24,568 | 67,842 | 13,731 |
| Pre-tax Income | -18,237 | 81,069 | 213,894 | 214,677 | 93,520 |
| Income Tax | -11,293 | 13,328 | 33,344 | 45,602 | -40,372 |
| Net Income Continuous | -6,944 | 67,741 | 180,550 | 169,075 | 133,892 |
| Net Income | $-6,944 | $67,741 | $180,550 | $169,075 | $133,892 |
| EPS Basic Total Ops | -0.09 | 0.85 | 2.18 | 2.00 | 1.58 |
| EPS Basic Continuous Ops | -0.09 | 0.85 | 2.18 | 2.00 | 1.58 |
| EPS Diluted Total Ops | -0.09 | 0.84 | 2.16 | 1.98 | 1.57 |
| EPS Diluted Continuous Ops | -0.09 | 0.84 | 2.16 | 1.98 | 1.57 |
| EPS Diluted Before Non-Recurring Items | 2.56 | 3.10 | 3.36 | 3.18 | 2.45 |
| EBITDA(a) | $174,897 | $241,202 | $364,064 | $324,096 | $294,892 |